ID: ALA315803

Max Phase: Preclinical

Molecular Formula: C10H11NO3

Molecular Weight: 193.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H](CC(=O)c1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C10H11NO3/c11-8(10(13)14)6-9(12)7-4-2-1-3-5-7/h1-5,8H,6,11H2,(H,13,14)/t8-/m0/s1

Standard InChI Key:  QXRCVKLRAOSZCP-QMMMGPOBSA-N

Associated Targets(Human)

Kynureninase 42 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 193.20Molecular Weight (Monoisotopic): 193.0739AlogP: 0.67#Rotatable Bonds: 4
Polar Surface Area: 80.39Molecular Species: ZWITTERIONHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.90CX Basic pKa: 8.96CX LogP: -1.73CX LogD: -1.74
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.69Np Likeness Score: 0.38

References

1. Ross FC, Botting NP, Leeson PD.  (1996)  Synthesis of phosphinic acid transition state analogues for the reaction catalysed by kynureninase,  (22): [10.1016/S0960-894X(96)00483-0]

Source